Pacific Biosciences Of California (PACB)HHS awarded $57K

$57K

committed so far

Signed

Jan 26, 2026

Updated

Jul 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 11, 2025Federal contract · $83K obligatedDepartment of Agriculture awarded PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: $83K obligated to date
2. Jan 12, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news

What came next

1. Jan 28, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 3, 2026, Pacific Biosciences of California, Inc. (the “Company”) announced that, effective January 28, 2026, Mark Van Oene, the Company’s Chief Operating Officer, will on an interim basis assume responsibilities for the Company’s sales and customer support organizations, which were previously assigned to Christian Henry, the Company’s President & Chief Executive Officer.”
2. Jan 30, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 1 more item)“On January 30, 2026, Pacific Biosciences of California, Inc. (the “Company”) completed the disposition of assets to Illumina Cambridge Limited (the “Buyer”) in accordance with the terms of an Asset Purchase Agreement, dated January 30, 2026 (the “Asset Purchase Agreement”), by and between the Company, the Buyer, and Illumina, Inc., solely for purposes of Section 8.16 of the Asset Purchase Agreement, pursuant to…”
3. Feb 12, 2026Company filing · Form 8-K · ResultsReported its results
4. Feb 26, 2026Federal contract · $75K obligatedDepartment of Health and Human Services awarded PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: $75K obligated to date
5. Mar 2, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 2, 2026, Michele Farmer notified Pacific Biosciences of California, Inc. (the "Company") that she is voluntarily resigning as Chief Accounting Officer of the Company effective on March 21, 2026, to pursue another opportunity.”
6. Mar 3, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 3, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Pacific Biosciences of California, Inc. (the “Company”), upon the recommendation of its Corporate Governance and Nominating Committee, increased the size of the Board to ten directors and appointed Christopher Gibson, Ph.D. to serve as a Class I director effective as of the Effective Date, with an initial term expiring at the Company’s…”
7. Mar 23, 2026Federal contract · $85K obligatedDepartment of Agriculture awarded PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: $85K obligated to date
8. May 7, 2026Company filing · Form 8-K · ResultsReported its results

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for Pacific Biosciences Of California

For Pacific Biosciences Of California, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 4 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PACB page.

How this filing works

• Contract ceiling vs obligated amount

Other disclosures at Pacific Biosciences Of California

• SEC Form 4Oct 8, 2026
• SEC Form 144Oct 6, 2026
• USAspending.gov award recordOct 1, 2026
• USAspending.gov award recordSep 29, 2026
• USAspending.gov award recordSep 18, 2026
• USAspending.gov award recordAug 31, 2026

Everything OQRO holds on this company is on its PACB page.